MoneyWorks4Me

Eris Lifesciences informs about company updates

17 Jun 2019 Evaluate

As per the requirements of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Eris Lifesciences has informed that it has enclosed the details of the related party transactions on a consolidated basis for the year ended 31st March, 2019 in accordance with the format prescribed in the relevant accounting standards.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..